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1. Introduction 
Soybean (Glycine max, L.) has been part of Southeast Asia culture for almost 2 millennia. 
However, only in the second half of the 19th century has it started being used in the Western 
world coinciding with the Chinese migration to the USA. Today, USA, South America, 
especially Brazil, and Northwestern Europe, account for almost 90% of the world total 
soybean production. At first, the nutrition value of soybean was attributed to its high 
quality protein content thus attracting considerable interest for its use in human diet. 
Nowadays, it is known that soybeans are a rich source of phytochemicals, and many of 
those compounds have important beneficial effects on human and animal health. 
Among the important phytochemicals in soybeans for human health, phytoestrogens, 
mainly, isoflavones (genistein and daidzein) and lignans, are the most widely studied. 
Nevertheless, saponins and phytosterols have also been the subject of research on soybeans. 
This chapter will discuss these phytochemicals compounds, their chemical structures, and 
their relationship with the major biological functions, scientifically proved, and their health 
benefits. 
2. Phytoestrogens   
Phytoestrogens are non-steroidal compounds found in plants. They demonstrate estrogenic 
and/or antiestrogenic activity and constitute a diverse group of compounds that have 
similar chemical structures and biological activity of estrogens. 
The phytoestrogens can be divided into four main classes: isoflavonoids, flavonoids, 
coumestrol and lignans. Nearly all food vegetables have phytoestrogens although the 
amount and concentration of the compounds vary significantly. Some vegetables are high in 
phytoestrogens content such as flaxseed, which are a rich source of lignans; soybeans and 
chickpeas have high concentrations of isoflavones. Lignans can also be found in cereals, 
vegetables, and fruits (Kuhnle et al., 2009), whereas isoflavone-containing foods, may be 
specially related and limited to grains and soy products such as tofu, soy beverages, soy 
flour, and soy flakes among others products, due to its high consumption. Discussions about 
the chemical structure and major properties such as the main biological functions will focus 
particularly on this type of phytoestrogen. 
2.1 Chemical structure and properties of phytoestrogens  
Phytoestrogens are intrinsic plant compounds and their contents depend on a number of 
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Among the phytoestrogens, isoflavones are found mostly in plants, especially in the 
glycosides forms and are biologically inactive. Soybeans are a main source of 
phytoestrogens in the human diet. Flavonoids are widely distributed throughout the plant 
kingdom and are found in many vegetables, grains, herbs, and green tea. As for the 
coumestrol, its only sources are alfalfa sprouts and a variety of bean seeds. Chemical 
structures of the four classes of phytoestrogens are shown in Figure 1. 
 
 
Fig. 1. Chemical structure of the major classes of phytoestrogens.  
The contents of isoflavones in soybean and soy products have been extensively analyzed 
and studied. Those studies have demonstrated that the concentration and composition of 
isoflavones vary considerably, which can be explained by environmental and geographical 
conditions as well as by the level of industrial transformation. Daidzein, genistein, and 
glycitein are the most abundant isoflavones found in soy. 
Isoflavones are naturally occurring compounds in foods as glycosides conjugated highly 
polar conjugated or non-conjugated form. For example, the textured soy protein and tofu 
have high contents of conjugated isoflavones such as daidzein and genistein, while 
fermented soy products such as miso, have approximately 90% of the isoflavones in non-
conjugated form, mainly daidzein and genistein (Coward et al., 1993). Those chemical 
structures and their similarity with equol and estradiol (human estrogen) can be seen in 
Figure 2.   
When ingested, phytoestrogens are metabolized by intestinal bacteria to equol (Cassidy, 
1996; Setcehll et al., 1984). The metabolism of phytoestrogens in humans is probably 
facilitated and modulated by bacterial colonies; therefore, the colonic ecology might be 
associated with increased efficiency in conversion of dietary soy isoflavones to their 
bioactive form (Teas et al., 2009). After absorption, isoflavones undergo enterohepatic 
circulation and are primarily conjugated with glucuronic acid in the liver and then excreted 
in urine. 
Numerous studies have shown that a number of factors influence the bioavailability of soy 
isoflavones. Xu et al. (1994) evaluated the bioavailability of daidzein and genistein from 
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soymilk and observed that daidzein was more bioavailable in adult women. The efficiency 
of absorption of soymilk isoflavones varies from 13% to 35% depending on individual gut 
microflora (Xu et al., 1995). Lampe et al., (1998) suggested that dietary fiber and other 
compounds in a diet rich in fibers might promote the growth and/or activity of bacterial 
colonies favorable to the conversion of daidzein to one of its catabolic products, equol, for a 
further absorption in the colon. Fermentation can reduce the isoflavones content in food 
products but increasing its bioavailability (Hutchins et al., 1995). Recently, it has been 
demonstrated in postmenopausal Japanese women that the bioavailability of isoflavones in 
fermented soy products rich in aglycones is much greater compared to the consumption of 
glucoside-rich non-fermented soybeans (Okabe et al., 2011). 
 
 
Fig. 2. Chemical structure of the major isoflavones found in soy and their similarity to equol 
and estradiol.  
2.2 Mechanisms of action and biological functions    
In recent years, it has been demonstrated that the phytoestrogens have multiple mechanisms 
of action. Such growing scientific evidence suggests that isoflavones are responsible for 
many of health benefits, which include the prevention and treatment of cardiovascular 
diseases, cancer, osteoporosis, and also for the relief of unpleasant pre- and post-menstrual 
symptoms. 
2.2.1 Reduction in risk of coronary heart diseases 
Coronary heart diseases are the leading cause of death especially in industrialized countries. 
High levels of total and LDL cholesterol are considered risk factors for these diseases. In 
humans, the consumption of 25g of soy protein per day may reduce the levels of total and 
LDL cholesterol 
Preliminary results suggest that isoflavones, such as estrogens, may produce a 
cardioprotector effect directly on blood vessel walls and on other processes involved in the 
etiology of coronary heart diseases although the results are sometimes incompatible. Soy 
isoflavones act as potent antioxidants able to reduce the oxidation of LDL cholesterol and to 
induce vascular reactivity. The presence of modified LDL cholesterol in the blood vessel 
www.intechopen.com
 
Soybean and Nutrition 
 
24
walls contribute to the formation of atherosclerotic plaques and, according to studies in 
humans, soy isoflavones improve endothelial function and arterial relaxation.  
Nagarajan (2010) suggested that soy isoflavones may inhibit the effect of endothelial cell 
activation associated to chronicle diseases such as atherosclerosis by blocking the activation 
of inflammatory cells and the adhesion to the vascular endothelium. This author concluded 
that the atherosclerotic protection of soy isoflavones is mediated through the regulation of 
monocyte activation (Figure 3). Another mechanism associated with soy isoflavones 
regarding cardiovascular health has been demonstrated by the reduction of vascular 
contraction through inhibition of the RhoA/Rho-kinase signaling pathway, which has a 
major role in muscle contraction (Seok et al., 2008).  
 
 
Fig. 3. (I) Inflammatory process associated with atherosclerosis. (II) Soy/isoflavone diet 
blocks endothelial and monocytes activation (Adapted from Nagarajan, 2010). 
A prospective study carried out in Japan showed that the high consumption of isoflavones 
was associated with reduced risk of cerebral and myocardial infarctions in women, mainly 
in postmenopausal women, suggesting that the consumption of dietary isoflavones may be 
beneficial for the prevention of cardiovascular diseases (Kokubo et al., 2007).  
Isoflavones may have inhibitory effects on the adipose tissue that could help prevent 
obesity-associated diseases by improving the plasma lipid profile. Nevertheless, in vivo 
studies, especially in humans, have demonstrated that the mechanisms of action of soy 
isoflavones seem to be dependent upon interactions between some other factors, such as the 
presence of soy protein and intestinal bacteria (Ørgaard & Jensen, 2008).  
Cardiovascular health benefits of soy isoflavones are controversial. It has been suggested 
that a genistein supplemented diet (Villa et al., 2009) improves the glycemic and vascular 
reactivity indexes in postmenopausal women compared to the control. Nonetheless, 
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discrepancies in clinical studies may be associated with the differences in intestinal bacterial 
flora of subjects and, therefore, with the bioavailability of soy isoflavones metabolites, 
differences in dose-response effects, duration of isoflavones supplementation, and the 
limited number and metabolic status of subjects included in supplementation trials (Siow & 
Mann, 2010) 
2.2.2 Anticancer effects 
Most of the evidences of the phytoestrogens effects on humans are epidemiological and are 
based on the differences in the consumption of soy products in different areas of the world, 
considering soy products as the major source of isoflavones. A recent publication of a meta-
analysis of a prospective study suggested that the consumption of isoflavones is associated 
with a reduced risk of breast cancer incidence in Asian populations (Dong & Qin, 2011). 
Accordingly, anticancer effects of soy isoflavones have been reported on prostate and colon 
cancer. The mechanisms that define the anticancer effects of isoflavones have also been 
reported in several studies that suggest various cellular pathways of the functional role as 
an anticancer agent.  
Studies have demonstrated that isoflavones prevent the growth of a variety of cells 
including those that are not hormone-dependent, these effects are based on the capacity of 
isoflavones to inhibit the activity of enzymes that control cell growth. Recently, it has been 
proved that dietary genistein may reduce breast cancer progression via transcriptional 
regulation of Rho GTPases and PAK (Martínez-Montemayor et al., 2010). Genistein acts as 
an inhibitor of the tyrosine-kinase activity, essential enzyme in the biological control of cell 
growth and differentiation. 
Another mechanism proposed for the anticancer activity of isoflavones was demonstrated 
by the inhibition of angiogenesis. Guo et al. (2007) found that soy isoflavones may inhibit 
prostate tumor angiogenesis through the suppression of vascular endothelial growth factor 
signaling pathways between tumor cells and vascular endothelial cells. Similar results were 
found by Su et al., (2005) in human bladder cancer cells lines. These authors demonstrated 
that isoflavones did not exhibit toxicity to normal bladder cells due to their angiogenic 
inhibitor effects.    
In prostate cancer cell lines has been observed that genistein significantly decreased reactive 
oxygen species levels and induce the expression of antioxidant enzymes such as manganese, 
superoxide dismutase and catalase through AMP-activated protein kinase (AMPK) 
activation and increase PTEN expression (phosphatase and tensin homolog deleted from 
chromosome 10) (Park et al., 2010). 
Based on in vitro studies, it has been proposed that isoflavones antagonize tumor cell growth 
in different cell lines by inhibiting cell cycle and inducing apoptosis. Studies have showed 
that isoflavones act in the activation of apoptotic pathways. Isoflavones may to induce the 
formation of Smad-DNA complexes and phosphorylation of Smad2 and Smad3 indicating 
increased TGF-ǃ1 signaling, which has been associated with proapoptotic and antimitotic 
activities inducing the death of tumor cells (Davis et al., 2008; Yu et al., 2005).  
2.2.3 Pre- and post- menopausal effects  
Experimental and epidemiological evidences support the hypothesis that phytoestrogens 
have estrogenic and antiestrogenic effects in women. The biological effect varies according 
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to the woman’s biological phase. Hence in premenopausal women, the phytoestrogens act 
as antiestrogens when the estrogen levels are high, and they act as estrogen in 
postmenopausal women when the estrogen levels are low (Messina, 2000).  
2.2.3.1 Premenopause 
Studies of controlled intervention in premenopausal women suggest that phytoestrogens 
diet may produce estrogenic effects (Cassidy et al., 1994, 1995). The interest in soy’s 
hormonal effects on premenopausal women is based on potential antiestrogenic benefits 
evidenced in hormone-dependent cancers, such as breast cancer. Hence, frequent assays 
measure the plasma concentration of reproductive hormones and the menstrual cycle. A 
reduced risk of breast cancer is associated to a longer menstrual cycle, reduced estrogens, 
increase in sex hormone-binding globulin, and increase urinary excretion ratio of 2- to 16ǂ-
hidroxy estrogens (Kurzer, 2002). In a randomized study with 40 premenopausal women 
was demonstrated that a soy diet slightly increased menstrual cycle length by 1.8±0.7 days 
and significantly increased urinary isoflavonoid excretion compared to women fed a control 
diet (Brown et al., 2002).  In similar study, Hooper et al. (2009) found that the consumption 
of isoflavone-rich soy products significantly reduced concentrations of FSH and LH 
hormones that regulate the development, growth, puberty maturation, and reproduction 
processes in premenopausal women. Menstrual cycle length was increased by 1.05 days.  
A recently published study, carried out in 73,223 premenopausal Chinese women 
demonstrated that the consumption of soy protein or isoflavones was inversely associated 
with the risk of breast cancer, and the association was highly statistically significant (P for 
trend < 0.001)). Women who frequently consume a high amount of soy foods during 
adolescence and adulthood had a very low risk of developing breast cancer (Lee et al., 2009).    
A daily intake of soy textured protein containing 45mg of isoflavones alters the menstrual 
cycle in healthy premenopausal women by prolonging its length, especially in the follicular 
phase. This effect was not observed with soy protein free of isoflavones, supporting the 
evidence that soy phytoestrogens act as an endocrine regulator. Similar effects of 
phytoestrogens on the menstrual cycle have been reported in other studies; nonetheless 
Phipps et al (1993) reported an increase in the length of the luteal phase. This result is not so 
easy to explain since changes in the luteal phase length are associated almost exclusively 
with changes in the follicular phase. The luteal phase is extremely constant and difficult to 
modify (Ferin et al., 1993). 
2.2.3.2 Postmenopause 
Epidemiological and clinical data indicate that postmenopausal estrogen therapy provides 
protection against cardiovascular diseases, reduces osteoporosis, improves the cognitive 
function, and relieves the menopausal symptoms related to the major loss of ovarian 
estrogen (Col et al., 1997). Alternative sources of exogenous estrogen have been extensively 
investigated due to a possible increased risk of breast cancer associated with hormonal 
replacement therapy (Brechkwoldt et al., 1995). Various studies have focused on verifying 
the potential of soy isoflavones as a source of exogenous estrogen. 
During menopause, the ovarian production of estrogens decreases. A reduction of estrogen 
levels in the blood leads a series of characteristic symptoms of menopause, such as hot 
flashes, insomnia, excessive sweating, headaches, mood swings, nervous tension, irritability, 
depression and vaginal dryness and pain. A group of 145 postmenopausal women was fed a 
diet rich in phytoestrogens (soy and flaxseed) and a control diet for 12 weeks. The subgroup 
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of women fed a phytoestrogen diet presented a significant lower incidence of hot flashes 
and vaginal dryness and an increase in the serial phytoestrogen concentrations (Brzezinski 
et al., 1997).  
A study involving 51 perimenopausal women who were fed a rich diet supplemented with 
isoflavones presented menopausal symptoms relief, reduction in the blood pressure, and 
improvements in the lipoprotein profile (Washburn et al., 1999). Similarly, a double-blind 
study involving 40 women who received daily doses of 100mg of isoflavones reported a 
decrease in menopausal symptoms and in the plasma levels of total and LDL cholesterol, 
which are risk factors for cardiovascular diseases (Han et al., 2002). Similar results were 
found in a study involving 58 postmenopausal women who consumed 45g of soy flour or 
45g of wheat flour. Those who consumed the soy flour presented a significant reduction of 
hot flash (Warren et al., 2002).      
2.2.4 Osteoporosis  
By the time a woman reaches menopause, her bone density (peak bone density is reached at 
approximately 30 years of age) decreases rapidly along with a reduction in estrogen in the 
plasma. If the estrogen replacement treatment starts before the onset of menopause, it is 
possible to prevent bone density loss as well as the risk of cardiovascular diseases in 
postmenopausal women. However, estrogen hormone replacement can also cause an 
increase in the risk of endometrial and breast cancer. 
The possibility that soy phytoestrogens may offer a natural alternative to the conventional 
hormone therapy for the prevention of bone loss has fostered research in animals and 
humans. Animal studies have used ovariectomized rats, although this is not an ideal model 
that simulates the influence of ovarian hormones on the reproductive physiology and bone 
loss in postmenopausal women; the findings are encouraging in terms of the protective 
effects of phytoestrogens. The consumption of soy isoflavone has demonstrated a 
significantly decreased in the number of osteoclasts and an inhibition of bone resorption 
after ovariectomy in this type of animals (Uchida et al., 2010). Analogously, it has been 
observed in ovariectomized rats, a reduction of urinary excretion levels of 
deoxypyridinoline, a specific biomarker of bone resorption, after the consumption of 
isoflavones with supplemental calcium (Breitman et al., 2003). Another study in rats 
demonstrated that genistein and moderate physical exercises prevented body weight gain 
and bone loss (Wu et al., 2004). 
Epidemiologic studies have showed a lower incidence of osteoporosis in populations 
consuming diets high in soy, such as Asians, when compared to western populations. Hip 
fracture is 50-60% less frequent among Asian compared to western women although this 
benefit gradually disappears as Asians adapt a western lifestyle (Adlercreutz & Mazur, 
1997; Roos et al., 1991, as cited in Lagari & Levis, 2010).   
3. Saponins  
In addition to the usual investigations on isoflavones as one of the main soy bioactive 
compounds, there has been a growing interest for investigating the functionality of soy 
saponins and their health benefits. 
Saponins (from the Latin “sapo”) constitute a vast group of glycosides that form foamy 
solutions in water exhibiting hemolytic and toxic effects in fish and invertebrates (Oleszek, 
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2000; Tsukamoto & Yoshiki, 2006). They are the major active constituents of many roots and 
corks that have been used by primitive people as a soap substitute (Fieser & Fieser, 1959). 
Saponins are usually located in the seed, hulls, leaves, stems, and roots of plants (Carlson, 
2009), and many of those compounds occur naturally even within a single vegetable species. 
Among the legumes, soy is one the main sources of saponins in the human diet (Lin & 
Wang, 2004). 
Saponins have an antifungal activity and a major role in defenses against predators in 
plants. This function has been traditionally associated with an anti-nutritional factor in 
foods containing saponins, besides having limited their application due to their bitter taste. 
However, recent studies have demonstrated the role of these compounds in the prevention 
and control of chronic degenerative diseases. 
3.1 Chemical structure and properties of saponins 
Saponins are compounds that have amphiphilic structure, i.e. having polar and non-polar 
fractions. The polar fraction is represented by one or more hydrophilic sugars chains linked 
to hydrophobic aglycon, triterpen or steroidal called sapogenin.  
Sapogenins are composed of carbon atoms in the form of fused rings. The sugars are in the 
form of oligosaccharides, linear or branched chains, although monosaccharides can also 
occur, such as the case of glucose and galactose. Both polar and non-polar groups are 
responsible for the beneficial biological effects. 
The structure of saponins from different plant sources varies depending on the types and 
amount of sugars as well as the composition of the steroid ring (Rao & Sung, 1995). In 
vegetables, steroidal saponins are mainly found in monocotyledons, and triterpene saponins 
are predominately present in dicotyledons such as leguminous plants, in which soy is 
considered as one of their major food sources (Güçlü-Üstündağ & Mazza, 2007). Galactose, 
arabinose, rhamnose, glucose, glucuronic acid, and fructose are the most common sugars in 
saponin structures, and five sapogenins have been identified in soybeans (Figure 4). Soy 
saponins are usually classified into three groups: A, B, and E (Lin & Wang, 2004) suggesting 
that saponins group E are formed from group B saponins during extraction and analysis 
when the 22-hydroxyl group is oxidized to a ketone (Berhow et al., 2006).  
As in most vegetables, the concentration of soy saponins depends on many factors, 
including the cultivar, age, physiological stage, geographical location, processing, and 
storage. Similarly, there are qualitative and quantitative variation also exists between plant 
parts (Oleszek, 2000). 
The contents of saponins in soybeans can vary among the different genotypes. In a study 
conducted in the USA, 21 lines of soybean grown in five different environments were 
evaluated. The contents of saponins found were between 2209 and 5830 µg.g-1 among the 
different lines and locations (MacDonald et al., 2005). The saponin content in the grain 
varies, and the highest amount is found in the hypocotyl, where there is a 4-fold 
accumulation compared to that of cotyledon and pod shell (Shimoyamada et al., 1990).    
Saponins are thermal sensitive, and several studies have evaluated the characteristics and 
stability of saponins in a number of soy products. During processing and storage of 
soybeans, chemical modification of saponins can occur resulting in a change in the total 
content, composition, and properties/biological activity and properties, which may or may 
not be desirable (Güçlü-Üstündağ & Mazza, 2007). 
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The cooking process of legumes as soybean reduces the amount of saponins by 7-53% (Shi et 
al., 2004). Soy-based foods have different amounts of saponins; usually low values 
compared to those of raw soybeans. Soybean flour, soy protein isolate, lecithin, and tofu 
present reduced content of saponins, 50, 25, 73, and 37%, respectively, compared to that of 
the whole soybeans (Fenwick & Oakenfull, 1981). Soy-based foods obtained by ethanol 
processes, such as concentrated proteins, for example, present low content of saponins due 
to their solubility in alcohol (Murphy et al., 2008). 
 
 
Fig. 4. Structures of five types of sapogenins identified in soybeans (Adapted from de Lin & 
Wang, 2004). 
3.2 Mecahisms of action and biological functions  
Due to recent advances in analysis and purification techniques of saponins, several studies 
have evaluated the functionality of these compounds influenced by the genetic 
polymorphism of their different structures (Tsukamoto & Yoshiki, 2006). Hence, saponins 
have been reported to possess a wide range of biological activities (Güçlü-Üstündağ and 
Mazza, 2007), mainly anticancer, antioxidant, hypocholesterolemic, and antiviral effects.    
3.2.1 Anticancer and antioxidant effects  
The biological oxidation caused by reactive oxygen species (ROSs) and free radicals is 
involved in biological processes such as aging and degenerative diseases such as cancer. The 
etiology and pathogenesis of cancer are multifactorial and involve multiple steps that 
culminate into complex disarray of cell signaling. 
Today, there are no clinical studies evaluating the activity of saponins as an anticancer or 
antioxidant agent, and even considering the scanty experimental research in animals, 
information is still insufficient to provide pertinent conclusions. Most studies in the 
literature are limited to in vitro analysis with cell lines of colon, liver, and breast cancer, and 
several mechanisms of action are proposed, among which include direct cytotoxicity, 
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induction of apoptosis, antiestrogenic activity, inhibition of tumor cell metastasis, 
antimutagenic activity effect, bile acid binding action, and normalization of carcinogen-
induced cell proliferation (Kang et al., 2010). Saponins (such as diosgenin, Figure 5) have 
been demonstrated to target multiple cellular and molecular pathways in their functional 
role as cancer chemopreventive agents.            
 
 
Fig. 5. Schematic representation of plausible mechanism of action(s) of diosgenin (saponin) 
at the cellular level as a cancer chemopreventive agent (Adapted from Raju & Mehta, 2009)  
Soy saponins help preventing the development and reducing the number of tumors in rats 
(Konoshima & Takasaki, 2000). More recently, the effect of soy saponins on human colon 
cancer cells was evaluated leading to the conclusion that these compounds may be effective 
in preventing colon cancer by affecting cell morphology, cell growth, and cell proliferation 
enzymes. In this study, the saponins affected the cell growth in two different ways; by 
increasing the alkaline phosphatase activity while reducing protein kinase C activity to 
induce cell differentiation, or by inducing type II autophagic death (Tsai et al., 2010). 
The antioxidant activity of saponins is also related to their capacity to bind to cholesterol 
and prevent cholesterol oxidation. Group B saponins, abundant in soy, linked with 2, 3-
dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP) group, are responsible for 
preventing lipid peroxidation or degeneration of DNA and protecting proteins from free 
radical attack (Ruiz et al., 1996; Shi et al., 2004; Yoshiki et al., 1994).  
In addition to preventing cholesterol oxidation by the action of free radicals, group A and B 
saponins have antioxidant effects on rat liver microsome through the inhibition of lipid 
peroxidation (Nishida et al., 1993). Recently, a group of researchers isolated type I soy 
saponins, one of the main groups occurring in soybeans, showing that it presents a free 
radical scavenging activity comparable to that of ǂ-tocopherol inhibiting lipid peroxidation. 
In this study was also demonstrated that the treatment with soy saponins increases the 
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superoxide dismutase and catalase activity, essential for the control of free radicals (Lee et 
al., 2010).  Similarly, mice fed a soy extract rich in saponins exhibited a better profile of the 
antioxidants system with significant increase of superoxide dismutase, glutathione 
peroxidase, and glutathione S-transferase activities (Yang et al., 2011). 
Saponins may have a synergistic antioxidative effect in the presence of hydrogen donors 
such as phenol compounds. Iron and copper ions generate hydroxyl radicals through the 
Fenton reaction to facilitate biological oxidation. Saponins may also have a preventive 
antioxidant that prevents active oxygen from being generated during the chelation of these 
metal ions (Tsukamoto and Yoshiki, 2006).  
3.2.2 Hypocholesterolemic effects  
The amphiphilic nature of saponins can explain the hypocholesterolemic activity of these 
compounds. This activity has been attributed to saponins for years (Sautier et al., 1979; 
Sidhu & Oakenfull, 1986), and, in general, is associated with  their ability to interfere with 
cholesterol absorption through possible mechanisms of action such as the formation of 
insoluble complexes with cholesterol, affectation micelle formation, interference with bile 
acid metabolism, and/or the perturbation the unstirred water layer or brush border 
membrane characteristics of enterocytes due to their detergent-like properties (Cohn et al., 
2010).  
Afrose et al. (2010) demonstrated the hypocholesterolemic effects of saponins in laying hens 
suggesting that the reductions in the levels of serum and egg cholesterol are caused by the 
suppression of cholesterol synthesis and the promotion of cholesterol catabolism in the liver. 
In another study, Zhao et al., (2008) proved these effects in hamsters fed a diet 
supplemented with saponins, but they attributed the results to the substantial increase in 
fecal cholesterol loss and not to the reduction of cholesterol absorption or synthesis.        
3.2.3 Antiviral effects  
A glycoside saponin, glycyrrhizin, found in some roots, exhibited suppressive effects on the 
replication in vitro of HIV (Ito et al., 1988). Due to its structural similarity to soy saponins, 
several studies have investigated the antiviral effects of this compound on soybeans. 
Soybean saponins have been evaluated for their antiviral activity against in vitro HIV 
demonstrating that group B soy saponin inhibits HIV-induced cytopathic effects and virus-
specific antigen expressions (Nakashima et al., 1989).  The antiviral functions of soy 
saponins was also demonstrated in the herpes simplex virus type 1 (Hayashi et al., 1997; 
Ikeda et al., 2005).      
Group B saponins with arabinose as the second sugar has an inhibitory effect on human 
cytomegalovirus (HCMV), influenza A virus, and human immunodeficiency virus type 
1. The antivirus effect of soy saponins is not limited to inhibit cell permeability and 
protein synthesis but also exhibit virus inactivation activity (Tsukamoto and Yoshiki, 
2006). 
4. Phytosterols   
Phytosterols are compounds found in plants that have important functions, especially in the 
structure of cell membranes and in cellulose biosynthesis. Studies have suggested that due 
to structural and functional analogy of phytosterols and phytostanols with cholesterol, they 
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have properties to compete for incorporation into micelles inhibiting cholesterol absorption 
in the intestine and enhancing its elimination in the feces. 
Phytosterols, also called plant sterols, are found naturally in plants (Schneider et al., 2009; 
Harrabi, 2008) in small quantities. Their hypocholesterolemic properties come from their 
structural similarity to cholesterol (Kaloustian et al., 2008).  
Since the 1950s, beneficial effects of plant sterols have been observed due to decreases in the 
plasma cholesterol levels and a significant reduction in the incidence of atherosclerosis in 
chick fed a soybean diet; therefore, it is possible that some soy sterols interfere with 
cholesterol absorption in the intestine (Peterson et al., 1952). Since that time, there have been 
studies in animals and humans demonstrating the effects of these compounds on the 
reduction of plasma cholesterol. 
4.1 Chemical structure and properties of phytosterols 
Phytosterols are steroid alcohols derived from plants with resemblance to cholesterol, the 
predominant sterol found in animals, and also are similar in functions to cholesterol, 
especially in terms of structure and functions of cell membranes. These compounds are 
members of the triterpen family and, unlike cholesterol, include a methyl or ethyl group at 
carbon 24 (AbuMweis & Jones, 2008; Palou et al., 2005, Piironen et al., 2000). 
Phytostanols are formed from the saturation of the double bond at carbon-5, and they do not 
occur very frequently in nature. The term plant sterols is usually used to refer to 
phytosterols and phytostanols. A phytosterol can be converted to its similar phytostanol by 
enzyme activity in plants, in vivo, or by industrial hydrogenation.  
More than 200 phytosterols have been identified in the plant kingdom, and many are found 
in edible foodstuffs (Bradford & Awad, 2007). Their nomenclature is rather confusing due to 
the partial approval of international norms defined by the International Union of Pure and 
Applied Chemistry (IUPAC) and the International Union of Biochemistry (IUB) (Moreau et 
al., 2002). 
The most common and widely studied phytosterols are sitosterol or β-sitosterol 
estigmasterol and campesterol. Other relevant phytosterols that can be found in plants in 
minor amounts are brassicasterol, ∆5-avenasterol, sitostanol and campestanol (Fernandes & 
Cabral, 2007). Figure 6 shows the chemical structures of the common phytosterols and 
phytostanols and their similarity to animal cholesterol. 
In addition to the free form, phytosterols can be found as conjugated or esterified 
compounds, in which the 3ǃ-hidroxyl group is esterified to fatty acids, glycosides, or 
phenolic compounds with different chemical, technological, and nutritional properties 
(Figure 7). The occurrence of these classes varies between the foods and parts of these foods 
(Palou et al., 2005; Piironen & Lampi, 2004). Vegetable oils are, in general, rich in free 
phytosterols and their fatty acid esters (Piironen & Lampi, 2004) although there is a great 
variability in the contents of free and esterified phytosterols in many types of oils and fats 
(Phillips et al., 2002). Nuts also contain high amounts of phytosterols (Piironen & Lampi, 
2004). Due to the wide variety of soy-based food products for human consumption, it is 
considered an important dietary source of phytosterol, and it can contribute significantly to 
the consumption of those products. A study involving 510 soybean cultivars showed that 
the content of phytosterols ranged from 202 and 843 µg.g-1. The highest amounts are found 
in soybeans with high lipid content. ǃ-sitosterol, campesterol, and estigmasterol were the 
main phytosterols found in the grain at the proportions of 43-67%, 17-34%, and 10-30%, 
respectively (Yamaya et al., 2007). Germinated soybeans have higher levels of phytosterols, 
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Fig. 6. Chemical structures of cholesterol, phytosterols and their saturated derivatives   
(Adapted from Yankah, 2006). 
 
. 
Fig. 7. Modification of 3ǃ-OH group in phytosterols (Adapted from de Palou et al., 2005).  
finding that has been corroborated recently in a study involving soybeans with 7 days of 
germination with phytosterol contents of 1004 and 1987 µg.g-1; the predominant phytosterol 
found was ǃ-sitosterol (Shi et al., 2010). 
Soy germ is rich in phytosterols. Therefore, the soybean oil produced is an important source 
of these compounds in countries where it is highly consumed. Studies cited by Piironen et 
al., (2000) indicated that the contents of phytosterols in raw soybean oil vary between 2,290 
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and 4,490 µg.g-1 and between 2,210 and 3,280 µg.g-1 in refined soybean oil. This type of oil 
showed lower loss of phytosterols in a continuous frying system compared with corn and 
sunflower oils (Winkler et al., 2007).   
4.2 Mechanisms of action and biological functions   
The intake of free phytosterols, especially ǃ-sitosterol and the esterified sources, has 
demonstrated properties of reducing serum cholesterol in animals and humans studies. 
According to the World Health Organization criteria, this biological function is fairly 
convincing, but further studies are necessary to demonstrate that this reduction is associated 
to the prevention of cardiovascular diseases. Other biological activities have also been 
attributed to the action of phytosterols such as antioxidant activity, cancer prevention, and 
immune system improvement. Nevertheless, those studies are considered insufficient to 
corroborate these hypotheses (de Jong et al., 2008).  
4.2.1 Hypocholesterolemic effects  
The functions of phytosterol in plants are similar to those of cholesterol in animals. They 
have an important role in the structure of the vegetable cell membranes acting as regulators 
of membrane fluidity and permeability by affecting the proteins associated to membranes 
(Alignan et al., 2009; Piironen et al., 2000; Roche et al., 2008). In addition to this structural 
function, phytosterols also act as precursors of a group of factors related to the growth of the 
plant. They act in the biosynthesis of cellulose and as substrates for secondary vegetable 
products such as alkaloids, cardenolides, and saponins (Palou et al., 2005; Peng et al., 2002; 
Piironen et al., 2000; Read & Bacic, 2002;). Phytosterols can also act as biogenetic precursors 
of a number of metabolites including plant steroid hormones, such as brassinosteroids and 
are involved in embryogenesis (Alignan et al., 2009; Breinhölder et al., 2002; Schaller, 2003). 
Scientific evidences demonstrate that phytosterols interfere in the reduction of cholesterol 
absorption stimulating a subsequent synthesis of the endogenous cholesterol. This leads a 
reduction in the plasma cholesterol levels and an increase elimination of cholesterol in the 
feces. The way by which phytosterols reduce cholesterol absorption has not been defined 
yet; however, there are evidences that indicate that the phytosterols compete with 
cholesterol for the micelles of absorption in the intestine. 
Studies have demonstrated serum cholesterol-lowering effect of phytosterols when 
consumed at levels of 1.5-2 g per day (Piironen & Lampi, 2004).  An increase in the rate of 
endogenous cholesterol synthesis caused by the action of phytosterols leads to an increase 
LDL-receptor activity in the liver and an increase of the number of LDL receptors in order to 
capture the cholesterol from these lipoproteins for the bile acid synthesis thus increasing 
elimination of LDL from circulation. Finally, the levels of LDL cholesterol, and therefore, 
total cholesterol in humans decrease without affecting the levels of HDL cholesterol and 
triglycerides (Palou et al., 2005). 
The contents of phytosterols in soy and its products are relatively too low to cause relevant 
effects in the reduction of cholesterol levels, which has attracted the interest of industries in 
the development and improvement of soy-based products.  
A clinical study on the consumption of a soy drink enriched with 2.6 g of phytosterol was 
conducted in 50 subjects (19 men and 31 women) for eight weeks, aged between 19 and 65 
years with moderate hypercholesterolemia. The study found that the regular consumption of 
200 ml of soy drink enriched with plant sterols reduces significantly the level of LDL 
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cholesterol by approximately 0.29 mmol.L-1 or 7% compared to baseline. The reduction in the 
levels of total, LDL and non-HDL cholesterol were significant greater than in the placebo 
group. Nevertheless, HDL cholesterol and triglycerides were not affected by the consumption 
of the drink, which was sensorally accepted by the subjects (Weidner et al., 2008). 
Accordingly, many studies have demonstrated and corroborated the effectiveness of 
phytosterols enriching various foods; margarine (AbuMweis et al., 2008), juices (Devaraj et 
al., 2003), milk (Plana et al., 2008; Hansel et al., 2007), and yogurt (Plat et al., 2009), 
evaluating cholesterol-lowering effect when consumed in the recommended dose.  
Recently, a meta-analysis of 84 clinical trials was conducted evaluating the effect of the 
enrichment of foods with phytosterols on subjects with hypercholesterolemia. The combined 
results of all studies grouped indicated that the reductions in the levels of LDL cholesterol 
were of 0.34 mmol.L-1 or 8.8% compared with control, for a mean daily dose of 2.15 g 
phytosterol. This study evaluated the impacts of subject baseline characteristics of the 
grouped studies through regression analysis suggesting that groups higher baseline LDL 
cholesterol resulted in greater absolute LDL cholesterol reductions, which could indicate the 
effectiveness of those foods in subjects with hypercholesterolemia (Demonty et al., 2009). 
Figure 8 shows the dose/response relationship in the reduction of LDL cholesterol levels in 
the grouped studies. 
 
 
Fig. 8. Dose-response relationship for the absolute (A) and relative (B) LDL cholesterol-
lowering effect of phytosterols (Adapted from Demonty et al.,  2009). 
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Soy-based products have high potential for phytosterols enrichment. Soy is considered a 
very important food due to its countless benefits, and its phytosterols and high quality 
protein can produce a synergic effect, which also has proved to reduce the levels of LDL and 
total cholesterol. 
4.2.2 Antioxidant effects  
Some studies suggest the hypothesis that phytosterols have antioxidant activity and may 
help the prevention of certain types of cancer (Awad et al., 2001; Normén & Andersson, 
2004; Wang et al., 2002). Nonetheless, the information available is still insufficient to 
corroborate those findings. 
In a study in mice was founded that phytosterols modulated and reduced the growth of 
tumors in ovariectomized female athymic (Ju et al., 2004). On the other hand, oxidant effects 
of phytosterols on biomarkers, such as DNA or lipid peroxidation, were not found in clinical 
studies (de Jong et al., 2008). The discrepancies between the results are frequently found in 
the literature.  
Emerging evidence supports the inhibitory actions of phytosterols on lung, stomach, 
ovarian and breast cancer, through multiple mechanisms of action, including inhibition of 
carcinogen production, cancer-cell growth, angiogenesis, invasion, metastasis and 
apoptosis. Phytosterol consumption may also increase the activity of antioxidant enzymes 
and thereby reduce oxidative stress (Woyengo et al. , 2009). 
5. Conclusions  
Soy is considered a rich source of proteins and lipids and contains other bioactive 
compounds such as isoflavones, saponins, and phytosterols. Such diversity in compounds 
makes it difficult to attribute an exclusive beneficial biological function to a single 
compound after consuming soy-based food products. For example, cholesterol-lowering 
effects are associated to the consumption of soy protein, but are also associated to 
phytosterols, isoflavones, and even saponins. Highlight the synergistic multicomponent 
effects of soy on biological functions would be a recommendation for further studies, as well 
as studies of the mechanism of action and new biomarkers for to prove the effectiveness of 
soy bioactive compounds in preventing and treating several symptoms and/or pathologies.  
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